TrialJournal of cancer research and clinical oncology2018

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.

David M Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.